Five Things to Know About Weight-Loss Drugs and IBD

(MedPage Today) -- As gastroenterologists seek better therapies for inflammatory bowel disease (IBD), they're closely watching the evolving data on GLP-1 receptor agonists. Could drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro...
Source
MedPage Today
Opens original article in a new tab



